# STIVARGA
> **NDA203085** · New Drug Application · Sponsor: BAYER HLTHCARE · Approved 2012-09-27
## Drug
- **FDA Application Number:** NDA203085
- **Application type:** New Drug Application
- **Brand name:** STIVARGA
- **Generic name:** REGORAFENIB
- **Active ingredients:** REGORAFENIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BAYER HLTHCARE
- **Manufacturer:** Bayer HealthCare Pharmaceuticals Inc.
- **First approval:** 2012-09-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203085)
---
*MORVS · CC0 1.0*